Status:
UNKNOWN
Evaluation of Renal Pretransplant Serology for BK Virus on the Risk of Post-transplant Viral Reactivation
Lead Sponsor:
Centre Hospitalier Universitaire, Amiens
Conditions:
BK Virus Nephropathy
Risk Factor
Eligibility:
All Genders
18+ years
Brief Summary
Due to the increasing importance of BKV infection on the survival of kidney transplants, a better knowledge, in the pretransplant phase, of the risk factors leading to viral reactivation could allow t...
Eligibility Criteria
Inclusion
- adult kidney transplanted patients
- Renal transplant patients with regular virological follow-up (blood and urine for BKV) during the first year after transplantation.
Exclusion
- Renal transplant patients with no follow-up for one year after transplantation (transplant failure, return to dialysis, death, follow-up outside the transplant centre)
Key Trial Info
Start Date :
September 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2023
Estimated Enrollment :
378 Patients enrolled
Trial Details
Trial ID
NCT04506060
Start Date
September 1 2020
End Date
December 1 2023
Last Update
February 8 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Amiens
Amiens, France, 80480